Maternal RSV immunization creates an important opportunity for obstetric and pediatric clinicians to coordinate newborn prevention strategies, according to Kevin Ault, MD.

Kevin Ault, MD, FACOG, explains that all four vaccines in ACOG's 2026-27 guidance carry direct newborn benefit and that prenatal conversations ease downstream pediatric vaccine discussions.

Drawing on her own successful version, Amber Watters, MD, welcomes the ASA's push for closer obstetrics and anesthesia collaboration.

SMFM states abortion care is core to MFM practice and urges institutional action to protect high-risk patient access.

Kevin Ault, MD, FACOG, emphasizes that obstetric clinicians are patients' most trusted vaccine information source, making maternal COVID-19 counseling a high-value opportunity.

FDA granted BTD to certolizumab pegol for preventing adverse pregnancy outcomes in women with antiphospholipid syndrome.

Amber Watters, MD, MS, explains how the ASA's statement encourages obstetric units to integrate neuraxial anesthesia into a formal external cephalic version process.

Kevin Ault, MD, FACOG, explains ACOG's extension of the maternal RSV vaccine window to March 1 and the role of passive immunity in protecting newborns.